What is the 13F Pro Quality Score for ALHC?

13F Pro ranks Alignment Healthcare, Inc. (ALHC) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View ALHC's current score at https://13fpro.ai/company/ALHC (free sign-up required for the full ranking).

Which hedge funds own the most ALHC stock?

Based on the most recent Form 13F-HR filings on SEC EDGAR, the largest reported institutional holders of ALHC include BlackRock,, WELLINGTON MANAGEMENT GROUP LLP, FMR. Holdings are reported quarterly within 45 days of quarter-end and updated on https://13fpro.ai/company/ALHC as soon as new 13F filings post.

Where does 13F Pro source ALHC data?

All Alignment Healthcare, Inc. fundamentals and ownership data come directly from SEC EDGAR. Alignment Healthcare, Inc. files with the SEC under CIK 1832466. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is ALHC in?

Alignment Healthcare, Inc. (ALHC) is classified in the Healthcare sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/healthcare.

What drives ALHC's revenue?

Per Alignment Healthcare, Inc.'s latest 10-Q filed with the SEC on 2026-07-30, the biggest revenue drivers are: Earned premiums ($1,326.6M, +31.8% YoY); Other ($9.0M, -0.8% YoY). Figures are extracted from the filing text and machine-verified against the document. Full breakdown at https://13fpro.ai/company/ALHC.

How often is ALHC research updated on 13F Pro?

ALHC's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

Alignment Healthcare, Inc.(ALHC)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Healthcare →Nasdaqmid

Institutional-grade research for retail investors

SEC EDGAR: CIK 1832466 ALHC stock profile & AI dashboard →

13F Pro Quality Score

64.2/100

Rank #566 of 2,961 stocksTOP 25%

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Revenue Growth

92.4/100

Profitability

44.0/100

Balance Sheet

62.8/100

Earnings Quality

97.4/100

Free Cash Flow

38.3/100

Institutional Flow

28.3/100

Revenue Scale

76.7/100

Dilution Risk

45.1/100

Email me the moment this company reports earnings

AI Research Report

Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.

Upgrade to Pro

Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.

Why ALHC Scores 64/100

exact factor attribution · 2026-09-11

ALHC's composite is driven by revenue growth and earnings quality, held back by free cash flow and institutional flow. Bars show each factor's exact push vs. a median company, using the same weights the ranking engine applies.

Revenue growth

+8.5 pts

92th pct

Earnings quality

+4.7 pts

97th pct

Scale

+4.0 pts

77th pct

Capital efficiency

+1.3 pts

63th pct

Shareholder dilution

-0.2 pts

45th pct

Earnings growth

-0.3 pts

44th pct

Profitability

-0.9 pts

44th pct

Institutional flow

-1.1 pts

28th pct

Free cash flow

-1.8 pts

38th pct

Latest change (2026-08-02): 63 → 58 · ↓ Free cash flow 56→35; ↓ Revenue growth 92→82

Factor percentiles are cross-sectional ranks across the ~2,800-stock scored universe, computed from SEC EDGAR filings. Not investment advice.

ALHC Stock Analysis & AI Quality Score

Data updated 2026-09-11

AI stock analysis and institutional research for Alignment Healthcare, Inc. (ALHC), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores ALHC at 64.2/100 on a 32-signal composite quality model, placing it at rank #566 of 2,961 stocks — the top 25% of the AI-ranked universe. ALHC scores in the top quartile across earnings quality (97.4), revenue growth (92.4), revenue scale (76.7). Areas of concern include institutional flow (28.3) and free cash flow (38.3), which score below median versus the broader universe. Shareholder dilution risk is elevated at 45.1/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), Alignment Healthcare, Inc. reports quarterly revenue of $1.3B, net income of $36.6M, an operating margin of 3.1%. Top institutional holders of ALHC by reported 13-F value include BlackRock, WELLINGTON MANAGEMENT GROUP LLP, FMR, based on the most recent SEC filings. ALHC trades on the Nasdaq exchange and files with the SEC under CIK 1832466. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ALHC daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Alignment Healthcare, Inc. directly from SEC EDGAR. Alignment Healthcare, Inc.'s 13F Pro composite quality score has ranged between 36 and 67 since 2022, currently 64.2 — an improving long-term trajectory across 64 quarterly and live scoring snapshots.

What's Driving ALHC's Business? Latest 10-Q Breakdown

✓ 17/17 datapoints verified

AI-extracted from Alignment Healthcare, Inc.'s 10-Q filed 2026-07-30 — Q2 FY2026 (quarter ended June 30, 2026). Every figure is machine-verified against the filing text on SEC EDGAR.

Revenue grew 31.6% YoY to $1,335.6M on 31.5% Health Plan Membership growth, while net income more than doubled to $36.6M as MBR improved to 86.3% and SG&A leverage kicked in.

Biggest Revenue Drivers

Earned premiums$1,326.6M+31.8% YoY

Increase primarily driven by growth in Health Plan Membership, which increased 31.5% YoY

Other$9.0M-0.8% YoY

Decrease mainly due to no longer participating in the ACO REACH program and lower third-party provider service revenue, partly offset by higher interest income

Biggest Revenue Drivers

Total revenue: $1,335.6M+31.6% YoY

Earned premiums$1,326.6M+31.8% YoY

Increase primarily driven by growth in Health Plan Membership, which increased 31.5% YoY

Other$9.0M-0.8% YoY

Decrease mainly due to no longer participating in the ACO REACH program and lower third-party provider service revenue, partly offset by higher interest income

Largest Expense Items

Medical expenses$1,154.7M+31.0% YoY

Driven primarily by Health Plan membership growth, higher benefits for members in certain plans, and an increase in unit costs

Selling, general and administrative expenses$131.0M+26.2% YoY

Increase due to ongoing investments in operations, technology, network development, and sales and marketing to drive membership growth

Depreciation and amortization$7.9M+12.2% YoY

Increase primarily due to the amount and timing of capital expenditures relative to 2025

Margins: Medical benefits ratio improved slightly to 86.3% from 86.7% YoY, and SG&A fell to 9.8% of revenue from 10.2% on economies of scale from membership growth, lifting income-from-operations margin to 3.1% from 2.3%.

Watch Items from the Filing

A former executive officer filed a whistleblower retaliation lawsuit on July 7, 2026 alleging he was terminated after reporting accounting irregularities; no accrual has been recorded.
Company's California HMO plan is under a CMS RADV audit for payment year 2019 with potential extrapolated overpayment findings, though a federal court vacated CMS's extrapolation rule in September 2025.
Recognized unfavorable prior year reserve development of $6.5 million in Q2 2026 due to worse-than-expected claims recoveries and higher-than-expected claims expense.
Operations concentrated in just five states (California, North Carolina, Nevada, Arizona, Texas), with California historically the largest market.
Discontinued third-party capitation arrangements as of January 1, 2026, removing a small but historically present revenue stream (capitation revenue fell to $0.3M in Q2 2026 from $1.6M a year earlier).

AI-extracted and verified against SEC EDGAR filing text. Not investment advice.

Read the full 10-Q on SEC EDGAR →Share on X

Revenue

Q2 2026

$1.3B

Net Income

Q2 2026

$36.6M

Free Cash Flow

Q2 2026

$-27.5M

Operating Margin

Q2 2026

3.1%

ROIC

Q2 2026

28.6%

D/E Ratio

Q2 2026

1.22

Period

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro

Revenue

+46.1% YoY

$3.95BFY 2025

FY22 $1.43BFY23 $1.82BFY24 $2.70BFY25 $3.95B

Net Income

+99.4% YoY

$-724.0KFY 2025

FY22 $-149.5MFY23 $-148.0MFY24 $-128.0MFY25 $-724.0K

Operating Income

+114.5% YoY

$14.8MFY 2025

FY22 $-128.6MFY23 $-127.8MFY24 $-101.6MFY25 $14.8M

EPS (Diluted)

+100.0% YoY

$0.00FY 2025

FY22 $-0.83FY23 $-0.79FY24 $-0.67FY25 $0.00

Total Assets

+36.3% YoY

$1.07BFY 2025

FY22 $633.9MFY23 $591.9MFY24 $782.1MFY25 $1.07B

Total Debt

+0.5% YoY

$323.2MFY 2025

FY22 $160.9MFY23 $161.8MFY24 $321.4MFY25 $323.2M

Op. Cash Flow

+302.4% YoY

$139.9MFY 2025

FY22 $-45.4MFY23 $-59.2MFY24 $34.8MFY25 $139.9M

Free Cash Flow

+1802.0% YoY

$113.1MFY 2025

FY22 $-69.2MFY23 $-95.2MFY24 $-6.6MFY25 $113.1M

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Revenue	$3.95B +46.1%	$2.70B +48.3%	$1.82B +27.2%	$1.43B +22.8%	$1.17B +21.7%	$959.2M
Net Income	$-724.0K +99.4%	$-128.0M +13.5%	$-148.0M +1.0%	$-149.5M +23.4%	$-195.3M -751.8%	$-22.9M
Operating Income	$14.8M +114.5%	$-101.6M +20.5%	$-127.8M +0.6%	$-128.6M +27.8%	$-178.1M -3283.5%	$-5.3M
EPS (Diluted)	$0.00 +100.0%	$-0.67 +15.2%	$-0.79 +4.8%	$-0.83 +27.2%	$-1.14 -660.0%	$-0.15
Total Assets	$1.07B +36.3%	$782.1M +32.1%	$591.9M -6.6%	$633.9M +0.5%	$630.9M +86.4%	$338.5M
Total Debt	$323.2M +0.5%	$321.4M +98.6%	$161.8M +0.6%	$160.9M +6.8%	$150.6M +4.5%	$144.2M
Operating Cash Flow	$139.9M +302.4%	$34.8M +158.7%	$-59.2M -30.3%	$-45.4M +42.3%	$-78.8M -1141.9%	$7.6M
Free Cash Flow	$113.1M +1802.0%	$-6.6M +93.0%	$-95.2M -37.5%	$-69.2M	—	—

Get alerted when ALHC's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for Alignment Healthcare, Inc. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of ALHC

BlackRock, Inc.
$460.6M19,342,956 sh
WELLINGTON MANAGEMENT GROUP LLP
$447.2M18,780,363 sh
FMR LLC
$331.5M13,924,329 sh
T. Rowe Price Investment Management, Inc.
$312.4M13,119,557 sh
VANGUARD PORTFOLIO MANAGEMENT LLC
$277.9M11,672,259 sh
Invesco Ltd.
$246.8M10,365,640 sh
BANK OF AMERICA CORP /DE/
$222.5M9,346,742 sh
VANGUARD CAPITAL MANAGEMENT LLC
$193.9M8,144,247 sh
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC
$184.8M7,761,403 sh
STATE STREET CORP
$173.8M7,297,494 sh

Fund	Value	Shares
BlackRock, Inc.	$460.6M	19,342,956
WELLINGTON MANAGEMENT GROUP LLP	$447.2M	18,780,363
FMR LLC	$331.5M	13,924,329
T. Rowe Price Investment Management, Inc.	$312.4M	13,119,557
VANGUARD PORTFOLIO MANAGEMENT LLC	$277.9M	11,672,259
Invesco Ltd.	$246.8M	10,365,640
BANK OF AMERICA CORP /DE/	$222.5M	9,346,742
VANGUARD CAPITAL MANAGEMENT LLC	$193.9M	8,144,247
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC	$184.8M	7,761,403
STATE STREET CORP	$173.8M	7,297,494

Companies Similar to ALHC

Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.

BTSG

BrightSpring Health Services, Inc.

AI score

Very similar · 18 shared holders

T. Rowe Price Investment Management, Inc.Capital Research Global Investors Integral Health Asset Management, LLC

NVST

Envista Holdings Corp

AI score

Similar quality profile · 15 shared holders

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)OBERWEIS ASSET MANAGEMENT INC/ROYCE & ASSOCIATES LP

IRTC

iRhythm Holdings, Inc.

AI score

Similar quality profile · 21 shared holders

TENOR CAPITAL MANAGEMENT Co., L.P.DeepCurrents Investment Group LLC LOOMIS SAYLES & CO L P

LFST

LifeStance Health Group, Inc.

AI score

Similar quality profile · 16 shared holders

Integral Health Asset Management, LLC LOOMIS SAYLES & CO L P FORMULA GROWTH LTD

TNDM

TANDEM DIABETES CARE INC

AI score

Similar quality profile · 21 shared holders

DeepCurrents Investment Group LLC LINDEN ADVISORS LP JACOBS LEVY EQUITY MANAGEMENT, INC

EYE

National Vision Holdings, Inc.

AI score

Similar quality profile · 8 shared holders

WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC Pier Capital, LLC JUPITER ASSET MANAGEMENT LTD

PTCT

PTC THERAPEUTICS, INC.

AI score

Similar quality profile · 17 shared holders

Hood River Capital Management LLC WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC LOOMIS SAYLES & CO L P

OPCH

Option Care Health, Inc.

AI score

Similar quality profile · 12 shared holders

LOOMIS SAYLES & CO L P GILDER GAGNON HOWE & CO LLC Cinctive Capital Management LP

Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.

More Healthcare Companies

View all Healthcare →

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

AARD

Aardvark Therapeutics, Inc.

ABBV

AbbVie Inc.

ABCL

AbCellera Biologics Inc.

ABEO

ABEONA THERAPEUTICS INC.

ABOS

Acumen Pharmaceuticals, Inc.

ABPWW

Abpro Holdings, Inc.

ABSI

Absci Corp

Put ALHC on your watchlist

Track score changes the day Alignment Healthcare, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is ALHC a good stock to buy?

13F Pro's AI-powered analysis of Alignment Healthcare, Inc. (ALHC) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for ALHC are available on the ALHC stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. ALHC is classified as a mid company.

Which hedge funds own ALHC?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling ALHC. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Alignment Healthcare, Inc.'s investment landscape.